• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏复律除颤器:当前及未来的适应症

Implantable cardioverter-defibrillator: present and future indications.

作者信息

Block M, Scheld H, Breithardt G

机构信息

Department of Cardiology-Angiology, Hospital of the Westfälische Wilhelms-University of Münster, Germany.

出版信息

Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.

PMID:8734176
Abstract

Indications for of automatic cardioverter-defibrillators of automatic in patients with ventricular tachyarrhythmias have changed since the publications of first guidelines in 1991. Less invasive surgical approaches reduced the perioperative mortality. Tiered therapy devices improved the quality of life by reducing appropriate and inappropriate shocks. A low annual incidence of sudden death with implantable cardioverter defibrillators and frustrating results with antiarrhythmic drugs caused an extension of implantable cardioverter-defibrillator indications. Despite the absence of prospective studies implantable cardioverter-defibrillators have become a first line treatment for patients with ventricular tachyarrhythmias which are not due to acute myocardial infarction. In cardiac arrest survivors implantable cardioverter-defibrillator therapy has become the gold standard due to the low annual incidence of sudden death seen in implantable cardioverter-defibrillator patients. The results of ongoing prospective studies comparing implantable cardioverter-defibrillator therapy to antiarrhythmic drugs have to be awaited and will influence tomorrow's indications for implantable cardioverter-defibrillator therapy in patients with documented ventricular tachyarrhythmias. Additionally, studies evaluating prophylactic implantable cardioverter-defibrillator implantations in patients at high risk for ventricular tachyarrhythmias might expand indications for implantable cardioverter-defibrillator therapy.

摘要

自1991年首次发布指南以来,心室快速心律失常患者使用自动心脏复律除颤器的指征已发生变化。侵入性较小的手术方法降低了围手术期死亡率。分层治疗设备通过减少适当和不适当的电击改善了生活质量。植入式心脏复律除颤器导致的猝死年发生率较低,以及抗心律失常药物效果不佳,使得植入式心脏复律除颤器的指征有所扩大。尽管缺乏前瞻性研究,但植入式心脏复律除颤器已成为非急性心肌梗死所致心室快速心律失常患者的一线治疗方法。在心脏骤停幸存者中,由于植入式心脏复律除颤器患者的猝死年发生率较低,植入式心脏复律除颤器治疗已成为金标准。比较植入式心脏复律除颤器治疗与抗心律失常药物治疗的正在进行的前瞻性研究结果有待观察,这些结果将影响未来有记录的心室快速心律失常患者植入式心脏复律除颤器治疗的指征。此外,评估在心室快速心律失常高危患者中预防性植入植入式心脏复律除颤器的研究可能会扩大植入式心脏复律除颤器治疗的指征。

相似文献

1
Implantable cardioverter-defibrillator: present and future indications.植入式心脏复律除颤器:当前及未来的适应症
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
2
Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.心脏性猝死的预防:植入式心律转复除颤器的作用
Mt Sinai J Med. 2005 Jan;72(1):1-9.
3
[The implantable cardioverter/defibrillator].[植入式心脏复律除颤器]
Herz. 1994 Oct;19(5):287-93.
4
[The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].[用于预防儿童和青少年心脏性猝死的植入式自动心脏复律除颤器]
Z Kardiol. 1993 Aug;82(8):466-73.
5
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.胸壁单极植入式心脏复律除颤器的多中心经验。主动除颤电极导线研究者。
J Am Coll Cardiol. 1996 Aug;28(2):400-10.
6
[Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].[室性心律失常的药物和非药物治疗的长期结果]
J Cardiol. 2000 Mar;35 Suppl 1:75-84.
7
[The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].[植入式心脏复律除颤器(ICD)。当前进展及未来展望]
Herz. 1994 Oct;19(5):246-50.
8
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.一项关于冠心病患者猝死预防的随机研究。多中心非持续性心动过速试验研究人员。
N Engl J Med. 1999 Dec 16;341(25):1882-90. doi: 10.1056/NEJM199912163412503.
9
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试:多中心ASSURE研究(心律失常单次电击除颤阈值测试与易损性上限:植入式心脏复律除颤器植入的风险降低评估)结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
10
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?植入式心脏复律除颤器电击是非缺血性心肌病患者心源性猝死的替代指标吗?
Circulation. 2006 Feb 14;113(6):776-82. doi: 10.1161/CIRCULATIONAHA.105.561571. Epub 2006 Feb 6.